
Center for Transgender Medicine and Surgery
@transcaresinai
The Mount Sinai Center for Transgender Medicine and Surgery is a comprehensive health program providing care for transgender and gender non-binary individuals.
ID: 1111380731928997888
https://www.mountsinai.org/ctms 28-03-2019 21:33:09
678 Tweet
1,1K Followers
117 Following

Mental & medical healthcare tailored to unique needs of LBGTQIA+ communities matters. As part of our work with Center for Transgender Medicine and Surgery & Alvin Bragg, we outline why resources for medical staff & pipelines for trans & nonbinary folks to join the field are needed: bit.ly/3JmrBIc


Last week of Michaela Sljivich, MD GURSjc fellowship almost done. Sad to say goodbye but excited to see what the future holds Mount Sinai Miami Beach Urology is getting a superstar. Mount Sinai Department of Urology Center for Transgender Medicine and Surgery



Our executive director Joshua Safer is in Israel joining in the training of primary care providers from across the country- expanding access to gender affirming healthcare for trans and gender diverse people!


A groundbreaking training course for family physicians on transgender care. Three full days with top professionals, providing exceptional exposure. Joshua Safer


A perfect activity for the end of #Pride month: joining Shimrit Arbel and Roy Zucker MD MSc with experience from Center for Transgender Medicine and Surgery - training primary care providers here in #Israel to expand care for transgender and gender diverse people here.

Our executive director Joshua Safer is ending #Pride month in #Israel with Roy Zucker MD MSc and Shimrit Arbel training primary care providers to expand health care for #trans and gender diverse people across the country.

Welcome to Mount Sinai Department of Urology Anne! So excited to have GURS matched Anne Yin from McGill University #reconstructiveurology Center for Transgender Medicine and Surgery


Blood clot risk in transgender women may not directly correlate with estrogen treatment. Read the latest from Center for Transgender Medicine and Surgery with lead author endocrinologist Daniel Slack: authors.elsevier.com/a/1joe4,YplMsl…

Great work by our Center for Transgender Medicine and Surgery Mount Sinai Health System Mount Sinai Department of Medicine Icahn School of Medicine at Mount Sinai team led by Daniel Slack and Joshua Safer showing that blood clot risk in trans women may relate to care access and not to estrogen treatment. authors.elsevier.com/a/1joe4,YplMsl…

Marci bowers from Center for Transgender Medicine and Surgery and WPATH president opens our 2024 conference in Portugal! Very excited to have over 1300 attendees and an enormous number of scientific presentations! So much to learn!


So excited to see our own Marci bowers from Center for Transgender Medicine and Surgery opening the 2024 WPATH scientific conference in Portugal. We have 17 Mount Sinai Health System Icahn School of Medicine at Mount Sinai presentations and are looking to learn much from the 1300+ other attendees!

Review by Rothman @DavidgePitts Joshua Safer and others The Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels Discussed at #WPATH2024 endocrinepractice.org/article/S1530-… and my editorial endocrinepractice.org/article/S1530-…

In Press #EndocrinePractice by Joshua Safer Center for Transgender Medicine and Surgery et al Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis. Risks of thromboembolism much lower than previously thought #WPATH2024 endocrinepractice.org/article/S1530-…

Thank you #EndocrinePractice for featuring work by Center for Transgender Medicine and Surgery Icahn School of Medicine at Mount Sinai Mount Sinai Department of Medicine Mount Sinai Health System Dr. Daniel Slack with me showing less blood clot risk in transgender women. Also presenting at #WPATH2024!

Cyproterone acetate (CPA) may not promote breast growth more than spironolactone when paired with estrogens in transgender women. Another reason CPA is not preferred say Center for Transgender Medicine and Surgery endocrinologists Daniel Slack and Joshua Safer. Read their comments: academic.oup.com/jcem/advance-a…

Cyproterone acetate (CPA) may not promote breast growth more than spironolactone when paired with estrogens in transgender women. Read why my Center for Transgender Medicine and Surgery Mount Sinai Department of Medicine colleague Daniel Slack and I think this is another reason CPA is not preferred. academic.oup.com/jcem/advance-a…
